HTWR: Summary for Heartware International, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:15am EST - Canadian Markets open in 9 hours and 15 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Heartware International Inc. (HTWR)

On Feb 9: 37.80 USD

0.21 (0.55%)

MORE ON HTWR

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Heartware International, Inc. (NGM:HTWR) Delayed quote data

After Hours: 37.80 0.00 (0.00%) as of 4:34pm EST on 02/09/10

Last Trade:	37.80 USD
Trade Time:	Feb 9
Change:	0.21 (0.55%)
Prev Close:	38.01
Open:	37.42
Bid:	37.50 x 100
Ask:	38.71 x 200
1y Target Est:	41.20

Day's Range:	37.40 - 37.98
52wk Range:	0.37 - 39.44
Volume:	137,916
Avg Vol (3m):	33,633.3
Market Cap:	15.48B
P/E (ttm):	N/A
EPS (ttm):	-0.07
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y

Add HTWR to Portfolio

Download Data

HEADLINES

•	HeartWare to Report 2009 Fourth Quarter and Year-End Financial Results
	PRNewswire (Mon, Feb 8)

•	Heartware stock sale exceeds estimates
	at bizjournals.com (Wed, Feb 3)

•	HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
	EDGAR Online (Tue, Feb 2)

•	HeartWare International, Inc. Announces Completion of Public Offering of Common Stock
	PRNewswire (Tue, Feb 2)

•	HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
	PRNewswire (Wed, Jan 27)

•	Heartware seeks around $50M via stock sale
	at bizjournals.com (Wed, Jan 27)

•	HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Other Events
	EDGAR Online (Tue, Jan 26)

•	HeartWare International, Inc. Announces Commencement of Public Offering of Common Stock
	PRNewswire (Tue, Jan 26)

•	HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Mon, Jan 11)

•	HeartWare to Present at J.P. Morgan Healthcare Conference in San Francisco
	PRNewswire (Wed, Jan 6)

More Headlines for HTWR...

ANALYST

EPS Est (next year) (Dec-09) :	-2.57
EPS Est (in 2 years) (Dec-10) :	-1.92
Avg Rec (current)*:	1.4
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

HeartWare International, Inc., a medical device company, focuses on developing and commercializing a family of blood pumps that are surgically implanted to help augment blood circulation in patients suffering from chronic and end-stage heart failure.

Full Company Profile

Add to Portfolio

Email to a Friend

•